Journal of Veterinary Medicine and Allied Science

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 1518081136

Commentary - Journal of Veterinary Medicine and Allied Science (2023) Volume 7, Issue 3

Updates in veterinary pharmacology and therapeutics: Highlights from the journal of veterinary medicine and allied science

David Simegn *

Department of Laboratory pathology, Hokkaido University, Sapporo , Japan

*Corresponding Author:
David Simegn
Department of Laboratory pathology, Hokkaido University, Sapporo , Japan
E-mail: david@eng.hokudai.ac.jp

Received: 01-June-2023, Manuscript No. AAVMAS -23-103077; Editor assigned: 02-June-2023, PreQC No. AAVMAS -23-103077 (PQ); Reviewed:15-June-2023, QC No. AAVMAS -23-103077; Revised:17-June-2023, Manuscript No. AAVMAS -23-103077 (R); Published:24-June-2023, DOI:10.35841/ aavmas-7.3.145

Citation: Simegn D. Updates in veterinary pharmacology and therapeutics: Highlights from the journal of veterinary medicine and allied science.. J Vet Med Allied Sci. 2023;7(3):145

Visit for more related articles at Journal of Veterinary Medicine and Allied Science

Introduction

Veterinary pharmacology and therapeutics form the foundation of veterinary medicine, ensuring the safe and effective use of medications to improve animal health. The Journal of Veterinary Medicine and Allied Science serves as a valuable platform for researchers and practitioners to share recent updates and advancements in this field. This introduction provides an overview of the importance of veterinary pharmacology and therapeutics, setting the stage for exploring key research areas and their implications for improving animal health outcomes. Drug Development and Pharmacokinetics: The journal features research articles on the development and pharmacokinetics of veterinary drugs. Studies investigate novel drug formulations, dosage regimens, and routes of administration to optimize therapeutic outcomes. Pharmacokinetic studies assess drug absorption, distribution, metabolism, and excretion in different animal species, enabling evidence-based dosing recommendations and minimizing the risk of adverse effects [1].

Antibiotic Stewardship and Antimicrobial Resistance: Antimicrobial resistance is a global concern in both human and veterinary medicine. The journal highlights research on antibiotic stewardship, emphasizing responsible antimicrobial use to combat resistance. Studies focus on optimizing antibiotic selection, dose optimization, and the development of alternatives to antimicrobial agents. Additionally, research explores strategies to promote judicious antibiotic use in veterinary practice to preserve the efficacy of these crucial medications [2] .

Anesthesia and Analgesia: Safe and effective anesthesia and analgesia are essential for minimizing pain and discomfort during surgical procedures and other veterinary interventions. The journal presents updates on anesthetic protocols, monitoring techniques, and pain management strategies. Studies investigate new anesthetic agents, refine anesthesia protocols for specific animal populations, and evaluate the effectiveness of analgesic medications and techniques to enhance postoperative pain management [3].

Pharmacogenomics and Personalized Medicine: Pharmacogenomics is an emerging field that explores the genetic basis for variations in drug response among different animal species and individuals. The journal features research on pharmacogenomics applications in veterinary medicine, including identifying genetic markers associated with drug efficacy and adverse reactions. Understanding these genetic variations allows for the development of personalized treatment approaches, improving therapeutic outcomes and reducing the risk of adverse drug reactions. Targeted Therapies and Immunotherapy: The future of veterinary pharmacology and therapeutics lies in the development of targeted therapies and immunotherapy approaches. Researchers are exploring novel drug delivery systems, immunotherapeutic interventions, and gene therapies to specifically target diseases in animals. These advancements have the potential to revolutionize the treatment of various conditions, including cancer, immune-mediated diseases, and infectious diseases [4,].

Pharmacovigilance and Drug Safety: As the field of veterinary pharmacology continues to evolve, ensuring drug safety and monitoring adverse drug reactions is of utmost importance. Future research will focus on pharmacovigilance, systematically collecting and analyzing data on adverse events associated with veterinary medications. This information will contribute to the development of robust drug safety profiles and allow for timely interventions to mitigate any potential risks. Integration of Digital Technologies: The integration of digital technologies holds great promise in veterinary pharmacology and therapeutics. Researchers are exploring the use of artificial intelligence, machine learning, and big data analytics to predict drug responses, optimize dosage regimens, and improve treatment outcomes. Furthermore, digital platforms and mobile applications are being developed to enhance medication management, adherence, and client communication in veterinary practice [5,].

conclusion

The Journal of Veterinary Medicine and Allied Science serves as a valuable resource for staying updated on the latest developments in veterinary pharmacology and therapeutics. The highlighted research encompasses diverse areas such as drug development, antibiotic stewardship, anesthesia and analgesia, and personalized medicine. The future of veterinary pharmacology and therapeutics lies in targeted therapies, pharmacovigilance, and the integration of digital technologies. By staying at the forefront of these advancements, veterinary professionals can provide safer and more effective treatment options, ultimately improving the health and well-being of animals..

References

  1. 1. 1.Momtazmanesh S, Moghaddam SS, Ghamari SH .Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 . EClinicalMedicine. 2023 1;59.

    2. Indexed at, Google Scholar, Cross Ref

  2. 2. 2.Butt MS, Imran M, Imran A, Therapeutic perspective of thymoquinone: A mechanistic treatise . Food Sci. Nutr. 2021 (3):1792-809.

    3. Indexed at, Google Scholar, Cross Ref

  3. 3. 3.Islam F, Shohag S, Akhter S,Exposure of metal toxicity in Alzheimer’s disease: An extensive review.. Biotechnol Annu Rev. 2008;14:203-24.

    4. Indexed at, Google Scholar, Cross Ref

  4. 4. Karami Fath M, Azami J, Jaafari N. Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid . Cell. Mol. Biol. Lett. 2022 D(1):1-28

    5. Indexed at, Google Scholar, Cross Ref

  5. 5. Butnariu M, Quispe C, Herrera-Bravo J. Papaver Plants: Current Insights on Phytochemical and Nutritional Composition Along with Biotechnological Applications. .Oxidative Medicine and Cellular Longevity. 2022 ;2022.

    6. Indexed at, Google Scholar, Cross Ref

Get the App